Predicted to enable alditol:NADP+ 1-oxidoreductase activity. Predicted to be located in cytoplasm. Predicted to be active in cytosol. Is expressed in central nervous system; embryo; and retina. Orthologous to human AKR1E2 (aldo-keto reductase family 1 member E2). [provided by Alliance of Genome Resources, Apr 2022]